1. Home
  2. Insider Trading Stock Activity
  3. Freeman Kevin Lee
Freeman Kevin Lee

Freeman Kevin Lee

Chief Commercial Officer of HCAT

Stock Insider Trading Activity of Freeman Kevin Lee

Freeman Kevin Lee

Chief Commercial Officer

Sell
HCAT Dec 1, 2024

Avg Cost/Share

$8.94

Shares

7,500

Total Value

$67,073.25

Owned After

236,950

SEC Form 4

Freeman Kevin Lee

Chief Commercial Officer

Sell
HCAT Sep 3, 2024

Avg Cost/Share

$7.22

Shares

7,500

Total Value

$54,174.00

Owned After

236,950

SEC Form 4

Freeman Kevin Lee

Chief Commercial Officer

Sell
HCAT Jun 11, 2024

Avg Cost/Share

$6.53

Shares

7,500

Total Value

$49,008.00

Owned After

236,950

SEC Form 4

Share on Social Networks: